Literature DB >> 15464657

Hepatic porphyrias: diagnosis and management.

Annie T Chemmanur1, Herbert L Bonkovsky.   

Abstract

Porphyrias are a group of metabolic disorders in which there are defects in the normal pathway for the biosynthesis of heme, the critical prosthetic group for numerous hemoproteins. The clinical manifestations of the porphyrias can be highly varied, and patients may present to general physicians and be referred to a wide variety of subspecialists because of these manifestations. However, two major clinical forms are represented by the so-called "acute" porphyrias, in which patients suffer recurrent bouts of pain, especially pain in the abdomen, and the "cutaneous" porphyrias, in which patients have painful skin lesions. Knowledge of the factors chiefly responsible for regulating the rate of synthesis of heme has helped to explain how drugs and other factors may cause porphyria. Knowledge of the physical and chemical properties of porphyrins also forms an important part of the foundation for understanding the clinical manifestations of these diseases. Thus, the porphyrias can best be understood after reviewing the chemical properties of porphyrins and heme and the control of their biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464657     DOI: 10.1016/j.cld.2004.07.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  9 in total

Review 1.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

Review 2.  Hepatitis C, porphyria cutanea tarda and liver iron: an update.

Authors:  F Ryan Caballes; Hossein Sendi; Herbert L Bonkovsky
Journal:  Liver Int       Date:  2012-04-17       Impact factor: 5.828

3.  Porphyria cutanea tarda as a complication of therapy for chronic hepatitis C.

Authors:  James Azim; Heather McCurdy; Richard-H Moseley
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

4.  Heme status affects human hepatic messenger RNA and microRNA expression.

Authors:  Herbert L Bonkovsky; Weihong Hou; Nury Steuerwald; Qing Tian; Ting Li; Judy Parsons; Alicia Hamilton; Sunil Hwang; Laura Schrum
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

Review 5.  Iron metabolism: from health to disease.

Authors:  Fernando Oliveira; Sara Rocha; Rúben Fernandes
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

6.  montalcino, A zebrafish model for variegate porphyria.

Authors:  Kimberly A Dooley; Paula G Fraenkel; Nathaniel B Langer; Bettina Schmid; Alan J Davidson; Gerhard Weber; Ken Chiang; Helen Foott; Caitlin Dwyer; Rebecca A Wingert; Yi Zhou; Barry H Paw; Leonard I Zon
Journal:  Exp Hematol       Date:  2008-06-11       Impact factor: 3.084

7.  Hepatitis-Induced Porphyria: Are Direct-Acting Antiviral Agents the Way of the Future?

Authors:  Jason J John; Richard K Sterling
Journal:  ACG Case Rep J       Date:  2021-05-14

8.  Erythropoietic protoporphyria masquerading as angioedema in a 4-year-old female.

Authors:  Helen C Wang; Ejaz Yousef
Journal:  Allergy Asthma Clin Immunol       Date:  2006-03-15       Impact factor: 3.406

9.  Butafenacil: A positive control for identifying anemia- and variegate porphyria-inducing chemicals.

Authors:  Jessica K Leet; Rachel A Hipszer; David C Volz
Journal:  Toxicol Rep       Date:  2015-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.